TTTetsuya Taga

Tetsuya Taga

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Tetsuya Taga has a total of 13 co-authors. Here are the top co-authors by number of shared publications:

  • Akihiko Yoshimura

    Division of Molecular and Cellular Immunology, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan

    1 shared publication
  • Aya Nonaka

    Division of Cell Fate Modulation, Institute of Molecular Embryology and Genetics, Kumamoto University, Honjo, Kumamoto, Kumamoto 860-0811, Japan,1 The 21st Century COE Cell Fate Regulation Research and Education Unit, Kumamoto University, Kumamoto, Japan,2 Center for Integrative Bioscience, Higashiyama, Myodaiji, Okazaki, Aichi 444-8585, Japan,3 Research Center for Advanced Science and Technology, Tokyo University, Komaba, Tokyo 4-6-1, Japan4

    1 shared publication
  • Hiroyuki Aburatani

    Division of Cell Fate Modulation, Institute of Molecular Embryology and Genetics, Kumamoto University, Honjo, Kumamoto, Kumamoto 860-0811, Japan,1 The 21st Century COE Cell Fate Regulation Research and Education Unit, Kumamoto University, Kumamoto, Japan,2 Center for Integrative Bioscience, Higashiyama, Myodaiji, Okazaki, Aichi 444-8585, Japan,3 Research Center for Advanced Science and Technology, Tokyo University, Komaba, Tokyo 4-6-1, Japan4

    1 shared publication
  • Hiroyuki Mori

    Division of Molecular and Cellular Immunology, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan

    1 shared publication
  • Kinichi Nakashima

    Laboratory of Molecular Neuroscience, Graduate School of Biological Sciences, Nara Institute of Science and Technology, 8916-5 Takayama, Ikoma 630-0101

    1 shared publication
  • Makoto Yanagisawa

    Department of Cell Fate Modulation, Institute of Molecular Embryology and Genetics

    1 shared publication

Latest Publications

  • Open Access

    Stabilized β-Catenin Functions through TCF/LEF Proteins and the Notch/RBP-Jκ Complex To Promote Proliferation and Suppress Differentiation of Neural Precursor Cells

    by Takeshi Shimizu, Tetsushi Kagawa, Toshihiro Inoue, Aya Nonaka, Shinji Takada, Hiroyuki Aburatani, Tetsuya Taga

    The proliferation and differentiation of neural precursor cells are mutually exclusive during brain development. Despite its importance for precursor cell self renewal, the molecular linkage between these two events has remained unclear. Fibroblast growth factor 2 (FGF2) promotes neural precursor cell proliferation and concurrently inhibits their differentiation, suggesting a cross talk between proliferation and differentiation signaling pathways downstream of the FGF receptor. We demonstrate that FGF2 signaling through phosphatidylinositol 3 kinase activation inactivates glycogen synthase kinase 3β (GSK3β) and leads to the accumulation of β-catenin in a manner different from that in the Wnt canonical pathway. The nuclear accumulated β-catenin leads to cell proliferation by activating LEF/TCF transcription factors and concurrently inhibits neuronal differentiation by potentiating the Notch1-RBP-Jκ signaling pathway. β-Catenin and the Notch1 intracellular domain form a molecular complex with the promoter region of the antineurogenic hes1 gene, allowing its expression. This signaling interplay is especially essential for neural stem cell maintenance, since the misexpression of dominant-active GSK3β completely inhibits the self renewal of neurosphere-forming stem cells and prompts their neuronal differentiation. Thus, the GSK3β/β-catenin signaling axis regulated by FGF and Wnt signals plays a pivotal role in the maintenance of neural stem/precursor cells by linking the cell proliferation to the inhibition of differentiation.


    • 1 March 2008
      • Vol. 53, 338-42

    [Molecular basis of cell fate regulation in the central nervous system].

    by Tetsuya Taga

  • Potentiation of Astrogliogenesis by STAT3-Mediated Activation of Bone Morphogenetic Protein-Smad Signaling in Neural Stem Cells

    by Shinji Fukuda, Masahiko Abematsu, Hiroyuki Mori, Makoto Yanagisawa, Tetsushi Kagawa, Kinichi Nakashima, Akihiko Yoshimura, Tetsuya Taga

    Astrocytes play important roles in brain development and injury response. Transcription factors STAT3 and Smad1, activated by leukemia inhibitory factor (LIF) and bone morphogenetic protein 2 (BMP2), respectively, form a complex with the coactivator p300 to synergistically induce astrocytes from neuroepithelial cells (NECs) (K. Nakashima, M. Yanagisawa, H. Arakawa, N. Kimura, T. Hisatsune, M. Kawabata, K. Miyazono, and T. Taga, Science 284:479-482, 1999). However, the mechanisms that govern astrogliogenesis during the determination of the fate of neural stem cells remain elusive. Here we found that LIF induces expression of BMP2 via STAT3 activation and leads to the consequent activation of Smad1 to efficiently promote astrogliogenic differentiation of NECs. The BMP antagonist Noggin abrogated LIF-induced Smad1 activation and astrogliogenesis by inhibiting BMPs produced by NECs. NECs deficient in suppressor of cytokine signaling 3 (SOCS3), a negative regulator of STAT3, readily differentiated into astrocytes upon activation by LIF not only due to sustained activation of STAT3 but also because of the consequent activation of Smad1. Our study suggests a novel LIF-triggered positive regulatory loop that enhances astrogliogenesis.